These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 18425487

  • 1. Maldi-TOF mass spectrometry for analyzing cell-free fetal DNA in maternal plasma.
    Ding C.
    Methods Mol Biol; 2008; 444():253-67. PubMed ID: 18425487
    [Abstract] [Full Text] [Related]

  • 2. Size fractionation of cell-free DNA in maternal plasma and its application in noninvasive detection of fetal single gene point mutations.
    Li Y, Holzgreve W, Hahn S.
    Methods Mol Biol; 2008; 444():239-51. PubMed ID: 18425486
    [Abstract] [Full Text] [Related]

  • 3. Qualitative and quantitative DNA and RNA analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Ding C.
    Methods Mol Biol; 2006; 336():59-71. PubMed ID: 16916253
    [Abstract] [Full Text] [Related]

  • 4. Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping.
    Lo YM.
    Transfus Clin Biol; 2006; 13(1-2):50-2. PubMed ID: 16563836
    [Abstract] [Full Text] [Related]

  • 5. Size fractionation of cell-free DNA in maternal plasma improves the detection of a paternally inherited beta-thalassemia point mutation by MALDI-TOF mass spectrometry.
    Li Y, Di Naro E, Vitucci A, Grill S, Zhong XY, Holzgreve W, Hahn S.
    Fetal Diagn Ther; 2009; 25(2):246-9. PubMed ID: 19506384
    [Abstract] [Full Text] [Related]

  • 6. Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay.
    Li Y, Page-Christiaens GC, Gille JJ, Holzgreve W, Hahn S.
    Prenat Diagn; 2007 Jan; 27(1):11-7. PubMed ID: 17154237
    [Abstract] [Full Text] [Related]

  • 7. Genotyping fetal paternally inherited SNPs by MALDI-TOF MS using cell-free fetal DNA in maternal plasma: influence of size fractionation.
    Li Y, Wenzel F, Holzgreve W, Hahn S.
    Electrophoresis; 2006 Oct; 27(19):3889-96. PubMed ID: 16972300
    [Abstract] [Full Text] [Related]

  • 8. Recent developments in the detection of fetal single gene differences in maternal plasma and the role of size fractionation.
    Li Y, Hahn S, Holzgreve W.
    Ann N Y Acad Sci; 2006 Dec; 1092():285-92. PubMed ID: 17308152
    [Abstract] [Full Text] [Related]

  • 9. Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry.
    Li Y, Finning K, Daniels G, Hahn S, Zhong X, Holzgreve W.
    Prenat Diagn; 2008 Mar; 28(3):203-8. PubMed ID: 18241084
    [Abstract] [Full Text] [Related]

  • 10. Detection and quantification of fetal DNA in maternal plasma by using LightCycler technology.
    Purwosunu Y, Sekizawa A, Okai T.
    Methods Mol Biol; 2008 Mar; 444():231-8. PubMed ID: 18425485
    [Abstract] [Full Text] [Related]

  • 11. Quantification of circulatory fetal DNA in the plasma of pregnant women.
    Zimmermann BG, Maddocks DG, Avent ND.
    Methods Mol Biol; 2008 Mar; 444():219-29. PubMed ID: 18425484
    [Abstract] [Full Text] [Related]

  • 12. High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: practice, problems and promise.
    Bray MS, Boerwinkle E, Doris PA.
    Hum Mutat; 2001 Apr; 17(4):296-304. PubMed ID: 11295828
    [Abstract] [Full Text] [Related]

  • 13. Analysis of single nucleotide polymorphisms by primer extension and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Fei Z, Smith LM.
    Rapid Commun Mass Spectrom; 2000 Apr; 14(11):950-9. PubMed ID: 10844731
    [Abstract] [Full Text] [Related]

  • 14. Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis.
    Liu FM, Wang XY, Feng X, Wang W, Ye YX, Chen H.
    Acta Obstet Gynecol Scand; 2007 Apr; 86(5):535-41. PubMed ID: 17464580
    [Abstract] [Full Text] [Related]

  • 15. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
    Bauer M, Hutterer G, Eder M, Majer S, Leshane E, Johnson KL, Peter I, Bianchi DW, Pertl B.
    Prenat Diagn; 2006 Sep; 26(9):831-6. PubMed ID: 16832830
    [Abstract] [Full Text] [Related]

  • 16. Advances in the research of fetal DNA in maternal plasma for noninvasive prenatal diagnostics.
    Vlková B, Szemes T, Minárik G, Turna J, Celec P.
    Med Sci Monit; 2010 Apr; 16(4):RA85-91. PubMed ID: 20357733
    [Abstract] [Full Text] [Related]

  • 17. Prenatal detection of beta-thalassemia CD17 (A-->T) mutation by polymerase chain reaction/ligase detection reaction/capillary electrophoresis for fetal DNA in maternal plasma--a case report.
    Yi P, Chen Z, Yu L, Zheng Y, Xie H, Zheng X, Liu Q, Han J, Li L.
    Fetal Diagn Ther; 2010 Apr; 27(1):25-31. PubMed ID: 19955703
    [Abstract] [Full Text] [Related]

  • 18. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND.
    Methods Mol Biol; 2008 Apr; 444():185-201. PubMed ID: 18425481
    [Abstract] [Full Text] [Related]

  • 19. Isolation of cell-free DNA from maternal plasma using manual and automated systems.
    Huang DJ, Mergenthaler-Gatfield S, Hahn S, Holzgreve W, Zhong XY.
    Methods Mol Biol; 2008 Apr; 444():203-8. PubMed ID: 18425482
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.